Search Results

In recognition of Pharmacy Technician Day today (October 18), ACCCBuzz spoke with Danielle Duy, CPhT, to learn more about her role on the multidisciplinary cancer care team.

The enormous out-of-pocket cost difference between well-covered traditional chemotherapies and often-uncovered oral oncolytics can result in levels of financial toxicity from which many patients struggle to return. To address this issue, the U.S. House of Representatives has this year reintroduced the Cancer Parity Act, which seeks to resolve unequal cost-sharing for oral oncolytics.

The topic of drug waste is nothing new in healthcare. Over the years, reports have surfaced attempting to put a dollar amount on this waste. In 2017, the Centers for Medicaid and Medicare Services began requiring all physicians, hospitals, and other providers submitting Medicare Part B drug claims to report any discarded amount of a single use vial or other single use package drug on its claim for …

Faced with the ever-growing cost of oral chemotherapy, our TPRxC team is passionate about securing financial support for our patients.